Argenta

Acquired

Healthy Animals. Let's Make It Happen, Together.

Auckland, New Zealand · Founded 2006

Headquarters
Auckland
Employees
501–1000
Founded
2006
Business Model
B2B
Last Round
Private EquityJan 2021
Rounds
1
Acquisition Date
Jul 2021

About

Argenta is the only global CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) focused exclusively on animal health and nutrition, complemented by regulatory expertise in human nutrition. Founded in 2006 in New Zealand by scientist Doug Cleverly, Argenta provides end-to-end Molecule to Market solutions including R&D, pre-clinical and clinical research, GMP manufacturing, and regulatory consultancy. With over 950 experts across facilities in New Zealand, the United States, the United Kingdom, Spain, and Germany, Argenta serves clients worldwide in veterinary pharmaceuticals, feed additives, and human nutrition.

Summary

Argenta is a Biotech company based in Auckland, New Zealand, founded in 2006. Its most recent funding was a Private Equity round in Jan 2021. Investors include KKR and NovaQuest.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionJul 2021

Sign up to see all 2 events

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Argenta on Indexed.vc
<a href="https://indexed.vc/companies/argenta"><img src="https://indexed.vc/api/badge/company/argenta" alt="Argenta on Indexed.vc" width="260" height="76" /></a>